Jiaxin He’s research while affiliated with Wuhan University and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


Figure 3 Distribution for different publication types of COVID-19-related and non-COVID-19 publications in global health journals in 2020: (A) distribution in each global health journal, (B) distribution in all global health journals.
Figure 4 JIF extracted from JCR, simulated JIF and simulated JIF without COVID-19-related publications for each global health journal from 2019 to 2021 JCR year. ESCI journals do not have actual JIFs from JCR and they are blank in the above figure. Publications in 2017 from Global Health Research and Policy and their citations were unavailable from WoS, resulting in absence of simulated JIF in 2019. The difference between A and B classifications according to the simulated JIFs from 2019 to 2021 is that, in B, the COVID-19-related publications were taken out of consideration in 2020. ESCI, Emerging Sources Citation Index; JCR, Journal Citation Reports; JIF, journal impact factor; WoS, Web of Science. on April 4, 2023 by guest. Protected by copyright.
The impact of COVID-19 on global health journals: an analysis of impact factor and publication trends Original research
  • Article
  • Full-text available

February 2023

·

221 Reads

·

16 Citations

Jiaxin He

·

·

Xinyang Lu

·

[...]

·

Background COVID-19 has affected research productivity across all areas of knowledge. Current evidence suggests that COVID-19 has had a blockbuster effect on journal impact factors (JIFs) and publication trends, while little is known on global health journals. Methods Twenty global health journals were included to analyse the impact of COVID-19 on their JIFs and publication trends. Indicator data, including numbers of publications, citations, articles with different types, etc, were extracted from journal websites and Web of Science Core Collection database. The JIFs from 2019 to 2021 were simulated for longitudinal and cross-sectional analyses. Interrupted time-series analysis and non-parametric tests were applied to assess whether COVID-19 had decreased non-COVID-19 publications from January 2018 to June 2022. Results In 2020, 615 out of 3223 publications were COVID-19 related, accounting for 19.08%. The simulated JIFs of 17 out of 20 journals in 2021 were higher than those in 2019 and 2020. Notably, 18 out of 20 journals had a decrease in their simulated JIFs after excluding COVID-19-related publications. Moreover, 10 out of 20 journals decreased their monthly numbers of non-COVID-19 publications after the COVID-19 outbreak. For all the 20 journals as a whole, after the COVID-19 outbreak in February 2020, the total number of non-COVID-19 publications significantly decreased by 14.2 compared with the previous month (p=0.013), and since then, on average, the publications had decreased by 0.6 per month until June 2022 (p<0.001). Conclusions COVID-19 has impacted the structure of COVID-19-related publications, the JIFs of global health journals and their numbers of non-COVID-19 publications. Although journals may benefit from increased JIFs, global health journals should avoid relying on a single metric. More follow-up studies including more years of data with a combination of metrics should be conducted to generate more robust evidence.

Download

Fig. 1 China's governance model against imported infections from international travelers
Fig. 2 China's governance model against imported infections from other vectors
The governance of imported 2019-nCov infections: What can be learned from China’s experience?

December 2022

·

52 Reads

·

7 Citations

Global Health Research and Policy

Delta and Omicron variants of 2019-nCoV are still spreading globally, and many imported infections have been identified in China as well. In order to control the spread chain from imported to local, China has implemented the dynamic Covid-zero policy. In this article we summarized China’s governance models and practices of fighting potential imported infections in two directions. One targets at international travelers, which can be outlined as four lines of defense: customs epidemic prevention, quarantine upon arrival, relevant laws and regulations, and community tracking. The other is against other vectors potentially carrying 2019-nCoV, which can be outlined by three lines of defense: customs epidemic prevention, disinfection and personal protection, and information management. However, there are still some challenges that are yet to be addressed, such as illegal immigration, accidental occupational exposure to 2019-nCoV, etc. China’s experience indicates that no country can stay safe during the global pandemic as long as there are local outbreaks in other countries, and active prevention and control measures based on science and a complete set of laws and regulations are still necessary at current stage. What’s more, accountable government commitment and leadership, strengthened health and social governance systems, and whole society participation are required. It is suggested that the global community continue to closely cooperate together and take active rather than passive actions to block the potential imported 2019-nCoV from causing local spreading.

Citations (2)


... ; https://doi.org/10.1101/2025.01.11.25320376 doi: medRxiv preprint contributions, which benefitted from fast publication tracks and great academic attention, putting research on other diseases and vaccines at considerable disadvantage. [14][15][16] In this work, we investigated the global patterns and drivers of scientific research on PSV, including studies on public attitudes, beliefs, emotions, trust, and uptake. To enable a fine-grained yet broad perspective on the literature, we selected a set of vaccines i.e., those against polio, measles, Human PapillomaVirus (HPV), influenza, and SARS-CoV-2, to be representative of different target populations, licensing and distribution histories, and viral pathogens with distinct transmission routes and epidemiology. ...

Reference:

Public sentiment towards vaccination: characterizing global patterns and drivers of scientific research
The impact of COVID-19 on global health journals: an analysis of impact factor and publication trends Original research